You have 9 free searches left this month | for more free features.

Lymphoma, T-Cell, Cutaneous

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

Remitoro in Recurrent or Refractory Peripheral T Cell Lymphoma

Recruiting
  • Lymphoma, T-cell, Peripheral
  • Lymphoma, T-cell, Cutaneous
  • Nagoya, Japan
  • +2 more
Nov 24, 2022

Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • Fungoides Mycosis Sezary Syndrome
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Jul 13, 2023

Skin Barrier and Microbiome of CTCL Patients

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
    • Leiden, Netherlands
      Centre for Human Drug Research
    Apr 21, 2023

    Cutaneous T-cell Lymphoma Retreated With Brentuximab Vedotin

    Not yet recruiting
    • T-Cell Lymphoma
    • No intervention
    • Bordeaux, France
    • +10 more
    May 24, 2023

    Cutaneous T Cell Lymphoma Trial in Chicago (APR-TD011 (RLF-TD011))

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • APR-TD011 (RLF-TD011)
    • Chicago, Illinois
      Dermatology CTU
    Feb 6, 2023

    Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,

    Not yet recruiting
    • Mycosis Fungoides of Skin (Diagnosis)
    • +5 more
    • Med-Jet Injector
    • +4 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 17, 2023

    Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Hypericin, Visible Light)

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • Mycosis Fungoides
    • (no location specified)
    May 23, 2023

    Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care

    Recruiting
    • Cutaneous T Cell Lymphoma
    • Peripheral T Cell Lymphoma
    • Microdevices
    • +2 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jul 16, 2022

    Tissue Repository: CTCL Collection Protocol

    Recruiting
    • Lymphoma, T-Cell, Cutaneous
    • +2 more
      • New York, New York
        Columbia University Medical Center
      May 2, 2022

      Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin, Mechlorethamine Topical Gel)

      Not yet recruiting
      • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
      • Fairport, New York
        Rochester Skin Lymphoma Medical Group
      Nov 20, 2023

      T-Cell Lymphoma Trial (Brentuximab vedotin)

      Not yet recruiting
      • T-Cell Lymphoma
      • Brentuximab vedotin
      • (no location specified)
      Jun 30, 2022

      Response to Gemcitabine Chemotherapy in Mycosis Fungoides

      Recruiting
      • Lymphoma, T-Cell, Cutaneous
      • Mycosis Fungoides
      • single-arm, non-randomized Biodynamic imaging (BDI)
      • Indianapolis, Indiana
        Indiana University School of Medicine, Department of Dermatology
      Nov 16, 2022

      T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)

      Not yet recruiting
      • T-cell Lymphoma
      • +10 more
      • Chicago, Illinois
        Rush University Medical Center
      Oct 24, 2022

      Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid

      Active, not recruiting
      • Mycoses
      • +5 more
      • anti-thymocyte globulin
      • +2 more
      • Stanford, California
        Stanford University School of Medicine
      Jun 16, 2022

      Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin)

      Completed
      • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
      • Fairport, New York
        Rochester Skin Lymphoma Medical Group
      Aug 24, 2022

      Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Mogamulizumab, Brentuximab vedotin)

      Not yet recruiting
      • Cutaneous T Cell Lymphoma
      • Mycosis Fungoides
      • (no location specified)
      Dec 7, 2022

      Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Madrid, Zürich (Atezolizumab)

      Active, not recruiting
      • Lymphoma, T-Cell, Cutaneous
      • Mycosis Fungoides/Sezary Syndrome
      • Madrid, Spain
      • +1 more
      Jul 1, 2022

      Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma Trial run by the NCI (Romidepsin,

      Recruiting
      • Cutaneous T-Cell Lymphoma
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United

      Recruiting
      • Folliculotropic Mycosis Fungoides
      • +7 more
      • Durvalumab
      • +2 more
      • Duarte, California
      • +3 more
      Jan 12, 2023

      Mycosis Fungoides Trial in Edmonton (Cemiplimab)

      Not yet recruiting
      • Mycosis Fungoides
      • Edmonton, Alberta, Canada
        Cross Cancer Institute
      Sep 12, 2022

      Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in New York (UVADEX® (methoxsalen) Sterile Solution in conjunction with the

      Recruiting
      • Cutaneous T Cell Lymphoma
      • Mycosis Fungoides
      • UVADEX® (methoxsalen) Sterile Solution in conjunction with the UVAR® THERAKOS® CELLEX Photopheresis
      • THERAKOS® CELLEX photopheresis system
      • New York, New York
        Herbert Irving Pavilion
      Dec 23, 2022

      Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL) Trial in United States (SIM1811-03)

      Recruiting
      • Advanced Solid Tumor
      • Cutaneous T-cell Lymphoma (CTCL)
      • Detroit, Michigan
      • +5 more
      Oct 6, 2022

      Recurrent Anaplastic Large Cell Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Mature T- and NK-Cell

      Active, not recruiting
      • Recurrent Anaplastic Large Cell Lymphoma
      • +10 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 30, 2023